Concepedia

Vicki E. Miller

VE

Statistics

Publications

6

Citations

314

H-Index

6

Active since

2007

Affiliations

Brigham and Women's Hospital(Current)

Baylor College of Medicine

Emory University

National Institute of Allergy and Infectious Diseases

Moderna Therapeutics (United States)

Vicki E. Miller is an author at Brigham and Women's Hospital specializing in vaccine development, vaccination, and vaccine safety.

Top concepts

Publications per year

2007–2024

6

Publications

6

Long-Term Neurological Outcomes in West Nile Virus–Infected Patients: An Observational Study

Jill E. Weatherhead, Vicki E. Miller, Melissa N. Garcia et al. · American Journal of Tropical Medicine and Hygiene · 2015 · 112 citations · Full text

Depression after Infection with West Nile Virus1

Kristy O. Murray, Melissa Resnick, Vicki E. Miller · Emerging infectious diseases · 2007 · 75 citations · Full text

Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus–diphtheria–acellular pertussis vaccine: a randomised, double-blind, phase 2b trial

Cheryl Keech, Vicki E. Miller, Barbara Rizzardi et al. · The Lancet · 2023 · 54 citations

, , +8

Safety, tolerability, and immunogenicity of an adult pneumococcal conjugate vaccine, V116 (STRIDE-3): a randomised, double-blind, active comparator controlled, international phase 3 trial

Heather Platt, Christopher Bruno, Erik Buntinx et al. · The Lancet Infectious Diseases · 2024 · 41 citations

, , +6

Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 Coronavirus Efficacy (COVE) Trial

Hana M. El Sahly, Lindsey R. Baden, Brandon Essink et al. · The Journal of Infectious Diseases · 2022 · 19 citations · Full text

1–5 of 6